Musculoskeletal stiffness: FDA reporting patterns
86,510 FDA FAERS reports mention Musculoskeletal stiffness. 52,779 reports have a serious outcome flag.
Medicines named as suspect
- Etanercept: 14,454 reports
- Adalimumab: 12,978 reports
- Methotrexate: 10,343 reports
- Tofacitinib: 7,647 reports
- Tocilizumab: 6,674 reports
- Rituximab: 6,562 reports
- Leflunomide: 6,356 reports
- Abatacept: 6,239 reports
- Infliximab: 6,002 reports
- Secukinumab: 5,994 reports
- Hydroxychloroquine: 5,542 reports
- Sulfasalazine: 5,379 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.